In recent years the United Kingdom has experienced a disproportionate increase in healthcare costs, this has been caused by many factors, such as increased life expectancy and a decline in childhood mortality. However, healthcare expenditure growth does not necessarily result in better healthcare and therefore the health of a population does not always improve automatically. Many factors combine to determine the health of an individual. These can include the physical environment in which the individual lives, such as the adequacy of their housing or their working conditions, and socioeconomic factors such as level of employment. Therefore both objective and subjective notions of value must be considered when calculating the real cost of healthcare. As a consequence of fixed NHS budgets a system of rationing is used to decide how the healthcare budget is spent. Therefore not every patient will receive the drugs and interventions needed to survive. This has caused major health scandals in the UK, for instance the case of Child B in which an 8 year old leukaemia patient died as a result of the NHS refusing to pay for her treatment. Recent years has seen tabloid newspapers bring cases such as these into public focus making rationing a common topic of current debate. The main cause of this healthcare dilemma is the fact that there are not enough resources available for everyone and as a result sacrifices have to be made. This problem stems from the demand outweighing the supply. An increase in demand has resulted from demographic changes, frequent flyers, wastage, increasing expectations and technological advance. Related to this dilemma is the economic concept of opportunity cost which considers the value of what would be gained from using resources elsewhere. For example the more money is spent on drugs, the less money is spent on police and it could be argued therefore that crime has increased as a result of that initial purchase. Health economics involves evaluating opportunity cost and cost effectiveness. In order to make decisions direct patient costs, direct health service costs, indirect costs and intangible costs such as the impact on quality of life must be considered. Economic evaluation compares a variety of alternatives focusing on both costs and consequences. Deciding that one of these alternatives is cost effective does not necessarily mean that it is the cheapest option and is not related to being effective at reducing costs. Health economic evaluation techniques measure both cost and quality of life (QOL). Assessment of health related quality of life in the UK has been part of economic evaluations for over 30 years and a variety data collection instruments have been devised. These include questionnaires EQ-5D and SF-36, which are used as a measure of healthcare outcome and QALYs which measure both the quality and quantity of life gained from a given treatment or intervention. Humpheys, I. (July, 2015). Introduction to Healthcare Economics in the UK. Lecture at Swansea University. Pre-sessional English Programme, Swansea.
Humpheys, I. (July, 2015). Introduction to Rationing, Heath Economics and
Economic Evaluation. Lecture at Swansea University. Pre-sessional English Programme, Swansea *** Please accept both of the above as title in pre-lecture and title of actual lecture do not match.